IRhythm Technologies Inc
IRhythm Technologies Inc is listed today as iRhythm Technologies, Inc.: market value, financials and filings are on its company page.
Funding rounds
6 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| May 2014 | $27 M | No. 6 | $10 to $50 million | equity | SEC | |
| Mar 2013 | $15 M | No. 5 | $10 to $50 million | equity | SEC | |
| Nov 2012 | $4 M | No. 4 | $2 to $10 million | debt, options | SEC | |
| Apr 2011 | $22 M | No. 3 | $10 to $50 million | equity | SEC | |
| May 2010 | $10 M | No. 2 | $10 to $50 million | equity | SEC | |
| Apr 2009 | $7 M | No. 1 | $2 to $10 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
As the listed company iRhythm Technologies, Inc., its revenue in fiscal 2025 came from these product and service lines: Contracted third-party payors $392.23 million (52%), Centers for Medicare and Medicaid $179.35 million (24%), Healthcare institutions $125.61 million (17%), Non-contracted third-party payors $49.94 million (7%).
Annual report (SEC XBRL) · Dec 2025
IRhythm Technologies Inc chose not to state its revenue in its newest notice of a funding round (Mar 2015).
SEC Form D · Mar 2015
The industry group it chose in its notices: Other Health Care.
SEC Form D · Mar 2015
Products and services#
No products or services of IRhythm Technologies Inc are on record.
Investors#
9 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| New Leaf Venture Associates II, L.P. | Venture capital | not stated | not stated | Held Series C, D and E preferred stock, 10% owner (Form 3, 2016) | SEC Form 3 |
| New Leaf Venture Management II, L.L.C. | Venture capital | not stated | not stated | Held Series C, D and E preferred stock, 10% owner (Form 3, 2016) | SEC Form 3 |
| New Leaf Ventures II, L.P. | Venture capital | not stated | not stated | Held Series C, D and E preferred stock, 10% owner (Form 3, 2016) | SEC Form 3 |
| Norwest Venture Partners XII, LP | Venture capital | not stated | not stated | Held Series D and E preferred stock, 10% owner (Form 3, 2016) | SEC Form 3 |
| Norwest Venture Partners XI, LP | Venture capital | not stated | not stated | Held Series D and E preferred stock, 10% owner (Form 3, 2016) | SEC Form 3 |
| Novo Holdings A/s | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2016) | SEC Form 3 |
| Raymond W. Scott | Person | not stated | not stated | Held Series E preferred stock, director (Form 3, 2016) | SEC Form 3 |
| Synergy Life Science Partners L.P. | Fund or asset manager | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2016) | SEC Form 3 |
| Synergy Venture Partners, LLC | Venture capital | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2016) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 17 investors.
Largest shareholders today
Institutions holding iRhythm Technologies, Inc. shares, as of Sep 30, 2026.
- RTW Investments, LP$354 M9.28%
- BlackRock, Inc.$342 M8.94%
- Artisan Partners Limited Partnership$250 M6.53%
- Vanguard Portfolio Management LLC$225 M5.89%
- Vanguard Capital Management LLC$167 M4.36%
- BNP PARIBAS ASSET MANAGEMENT Holding S.A.$127 M3.32%
- Eventide Asset Management, LLC$103 M2.70%
- State Street Corp$98 M2.57%
- Geode Capital Management, LLC$98 M2.56%
- FMR LLC$95 M2.48%
- Invesco Ltd.$91 M2.37%
- UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC$87 M2.27%
- Fuller & Thaler Asset Management, Inc.$85 M2.22%
- Stephens Investment Management Group LLC$80 M2.10%
- Westfield Capital Management Co LP$77 M2.01%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Kevin M. King | Executive officer | Mar 2015 |
| Matthew M. Garrett | Executive officer | Apr 2013 |
| Shelly D. Guyer | Executive officer | Nov 2012 |
| Judith K. Lenane | Executive officer | Jan 2012 |
| Steve E. Johnson | Executive officer | Jan 2012 |
| William F. Willis | Executive officer | Jan 2012 |
| Judith N. Lenane | Executive officer | May 2011 |
| Uday N. Kumar | Executive officer | May 2011 |
| Uday Kumar | Executive officer | Apr 2009 |
| William Willis | Executive officer | Apr 2009 |
| Casper E. de Clercq | Director | Mar 2015 |
| Chris E. Grant | Director | Mar 2015 |
| Joshua L. Green | Director | Mar 2015 |
| Kevin M. King | Director | Mar 2015 |
| Raymond K. Scott | Director | Mar 2015 |
| Tiba N. Aynechi | Director | Mar 2015 |
| Vijay K. Lathi | Director | Mar 2015 |
| William N. Starling | Director | Mar 2015 |
| Sam E. Brasch | Director | May 2014 |
| Casper L. de Clercq | Director | Apr 2013 |
| Vijay N. Lathi | Director | Apr 2013 |
| R. Hardwin Mead | Director | Nov 2012 |
| Roberta R. Katz | Director | Nov 2012 |
| R. Hardwin R. Mead | Director | Jan 2012 |
| William F. Willis | Director | Jan 2012 |
| Uday N. Kumar | Director | May 2011 |
| Michael D. Goldberg | Director | May 2010 |
| Hardwin Mead | Director | Apr 2009 |
| Michael Goldberg | Director | Apr 2009 |
| Roberta Katz | Director | Apr 2009 |
| Uday Kumar | Director | Apr 2009 |
| William Starling | Director | Apr 2009 |
| William Willis | Director | Apr 2009 |
Went public since 2016. Its SEC number is that of a company listed on a stock exchange.